Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein.

Autor: Zhu Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Cui J; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Liu J; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Hua W; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Wei W; Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China., Sun G; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jazyk: angličtina
Zdroj: Cancer medicine [Cancer Med] 2020 May; Vol. 9 (10), pp. 3592-3603. Date of Electronic Publication: 2020 Mar 11.
DOI: 10.1002/cam4.2977
Abstrakt: Objective: To explore the biological function and molecular mechanism of Sp2 in hepatocellular carcinoma (HCC).
Methods: Tissue microarray immunohistochemistry and western blot were used to study the expression of Sp2 in hepatocellular tissue and adjacent non-neoplastic tissues (ANT). In HCC cell lines, the role of Sp2 was determined by in vitro experiments such as CCK8, clone formation test, Transwell assay, wound-healing assay, and flow cytometry apoptotic analysis, and its possible mechanism was analyzed.
Results: Compared with ANT, Sp2 expression in HCC tissues was significantly up-regulated, which was strongly associated with stage of tumor and poor prognosis of patients. TCGA database were further confirmed these results. Besides, functional studies had shown that Sp2 knockdown not only leads to a decrease in cell proliferation and an increase in cell apoptosis but also inhibits the cells' abilities of migration and invasion. Sp2 silencing could inhibit the expression of TRIB3 protein and down-regulate the endoplasmic reticulum stress (ERS) level of HCC.
Conclusion: Sp2 may play a part in promoting cancer by regulating TRIB3 protein, which may be a factor of prognostic and a potential new therapeutic target for HCC.
(© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje